Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies.
Journal: Clinical genitourinary cancer
Published: July 02, 2026
Divergent biology and outcomes of somatic transformations in germ cell tumors.
Journal: The oncologist
Published: April 20, 2026
Approach to the patient with metastatic pheochromocytoma and paraganglioma: advances in systemic therapy.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 12, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Journal: Clinical genitourinary cancer
Published: December 02, 2025
Genomic Landscape and Outcomes of Renal Cell Carcinoma With Metastases to the Pancreas.
Journal: JCO precision oncology
Published: November 06, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Journal: The oncologist
Published: June 09, 2025
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.
Journal: European urology
Published: May 07, 2025
Clinical Response to Enfortumab Vedotin and Pembrolizumab in a Patient with Vaginal Squamous Cell Carcinoma: A Case Report.
Journal: Case reports in oncology
Published: December 12, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data.
Journal: European urology oncology
Published: July 04, 2024
Last Updated: 09/26/2026